Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

Aravind Subramanian, Pablo Tamayo, Vamsi K. Mootha et al. · Proceedings of the National Academy of Sciences · 2005 · 56.7K citations · Full text

Life Sciences, Bioinformatics, Oncology +12

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

Andrea Bild, Guang Yao, Jeffrey T. Chang et al. · Nature · 2005 · 2.1K citations

Medicine, Cancer Biology, Oncology +14

A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance

Robert A. Kyle, Terry M. Therneau, S. Vincent Rajkumar et al. · New England Journal of Medicine · 2002 · 1.5K citations

Medicine, Oncology, Pathology +13

Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability

Rosalie C. Sears, Faison Nuckolls, Eric B. Haura et al. · Genes & Development · 2000 · 1.4K citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

Ola Landgren, Robert A. Kyle, Ruth M. Pfeiffer et al. · Blood · 2009 · 1.1K citations · Full text

Medicine, Hematology, Oncology +8